A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
4 days ago
This bill, designated as S. 4066 in the 119th Congress and introduced on March 11, 2026, aims to declare that the approved application for the drug mifepristone under the Federal Food, Drug, and Cosmetic Act for ending intrauterine pregnancies is considered withdrawn. Additionally, it seeks to create a Federal tort claim for harm caused to women by chemical abortion drugs along with other related purposes.
2
Comments

Emmett Tate
1 day ago
This bill is ridiculous.

Jase McClure
2 days ago
I think this bill is a bad idea. It's taking away a safe option for women who need it. It's not fair to punish women for seeking medical help. This bill could have serious consequences for women's health and rights. We need to stand up and fight against this. #ProtectWomen'sRights #StandUpForChoice The big picture here is that this bill could set a dangerous precedent for restricting access to reproductive healthcare in the United States. It's important to speak out and advocate for women's rights and healthcare options.